Abiomed Inc. announced that it has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for its Impella heart pumps to provide treatment of ongoing cardiogenic shock.

The Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Scientific Sessions took place May 4-7, 2016 in Orlando, Fla. The event included data from clinical trials on some of the latest advances in interventional cardiology. The late-breaking clinical trials presentations include the following, including links to related stories on these trials:

Wednesday, May 4, 1:15 - 2:15 p.m. Eastern Time

CompaMed - High Tech Medical Solutions Fair

The Centers for Medicare & Medicaid Services (CMS) announced its largest-ever initiative to transform and improve how primary care is delivered and paid for in America.

April 11, 2016 - The U.S. Food and Drug Administration (FDA) has approved the world's smallest pacemaker, the Medtronic Micra Transcatheter Pacing System (TPS). The device is the first FDA-approved product with miniaturized pacing technology that is cosmetically invisible and small enough to be delivered through a catheter. It is implanted directly into the heart, providing a safe alternative to conventional pacemakers without the complications associated with cardiac lead wires.

New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was generally consistent with the findings observed in the ROCKET AF Phase 3 study that supported approval of the medicine for prevention of stroke in patients with non-valvular atrial fibrillation (NVAF).

Depression is a known risk factor for cardiovascular disease, but as a person’s depression improves — or grows worse — their risk for heart disease has remained largely unknown.

Toshiba America Medical Systems Inc. has received authorization to operate (ATO) with the U.S. Air Force for its Aplio Platinum Series ultrasound systems.

April 7, 2016 — Circle Cardiovascular Inc. the world-leading developer of innovative cardiac MR (CMR) and cardiac CT (CCT) post-processing software announces the completion of a substantial financing round with participation from existing investors including BDC Capital and new investors, The Accelerate Fund and Epic Capital Management Inc.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now